Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apellis, Aquestive, Ascendis, Bavarian, Bioarctic, Eisai, Genmab, Grin, Oncopeptides, Pfizer, Pharvaris, Santen, Sydnexis.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Azmed, Restor3d, Teleflex, Zimmer Biomet.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Beigene, BMS, Halozyme, Ideaya, Moderna, Novartis, Otsuka.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Accuredit, Cstone, Junshi, Kelun-Biotech, Merck, Mirum, Nature Cell, Shanghai Henlius Biotech, Sungen Biomedical.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Epitel, Novartis, Visby Medical.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accuredit, Alteogen, BMS, Crinetics, Eli Lilly, Fresenius, Genmab, J&J, Merck, Milestone, Mirum, Sanoti, Shanghai Henlius, Takeda, Valneva.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: SS Innovations.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bridgebio, Fresenius Kabi, Genmab, Junshi, Savara, Soleno.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 4Moving, Abbott Labs, MedCAD, Restor3d, Vasorum.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alvotech, Exelixis, GSK, Intellia, Kashiv, Kelun, Merck, Neurim, Plus, Sanofi, Theratechnologies, Vast.